The Drugs of SNY

Subscribe to this blog

Awesome Potential

Tags: Accomplia, SNY
31 Aug 8:09am
Posted by sainox
0 Comments
   "Amusa estimates that by 2010, Acomplia will generate 4.2 billion euros per year in revenue ($5.2 billion)." - SmartMoney Although I can't be sure how often analysts are correct when they make these statements, with the success of the clinical trials and obesity problems in the US, this number can very much come to reality if the FDA will give its thumbs up. 2005 Total Revenue:              $36.5 billion 2...
Read the rest of this story

Accomplia Release in Europe

Tags: Accomplia, Obesity, CB1 blocker, Sanofi-Aventis, weight loss, Drugs, SNY
31 Aug 7:25am
Posted by sainox
0 Comments
June 21st 2006Sanofi-Aventis was granted marketing authorization for the new class(CB1 blocker) of obesity drugs in the 25 member states of the european member states.Stock prices edged up that day to $46.98.Sanofi-Aventis“The approval of ACOMPLIA® in the European Union is important news for obese and overweight patients with additional cardiometabolic risk factors such as type 2 diabetes or dyslipidaemia who will now have access to an innovative treatment option,”said Jean-François Dehecq, Ch...
Read the rest of this story

FDA Approves New Medical Use for Plavix

Tags: Plavix, SNY
31 Aug 7:23am
Posted by sainox
0 Comments
FDA approves new medical use of Plavix for treating a STEMI heart attack which plagues 500,000 Americans every year. These severe heart attacks are caused by total blockage of an artery.http://www.fda.gov/bbs/topics/NEWS/2006/NEW01431.htmlSanofi and Bristol-Myers continues to be plagued by competitor Apotex with cheaper generic version of Plavix. Court case to block the sales of the generic version underway.The generic version of blood-thinning drug Plavix being sold in the US since Aug 18 is ...
Read the rest of this story

Accomplia Updates

Tags: Accomplia, Obesity, Smoking, Drugs, SNY
22 May 10:41pm
Posted by fullmetal
0 Comments
Just a few updates on SNY's highly anticipated Accomplia release: Diet Drug Acomplia May Be Available for Purchase in July in Britain or Germany "Hanspeter Spek, executive vice president, pharmaceutical operations, Sanofi-Aventis, told financial analysts on May 5th that Sanofi is "very active in preparing for our first launches," which almost surely will take place in Europe and not the United States. A key committee of the European Medicines Agency (EMEA), the Committee for Medicinal Produ...
Read the rest of this story

Bird Flu Vaccine moving in Development

Tags: Bird Flu, Vaccine, SNY
2 May 2:56pm
Posted by sainox
0 Comments
Bloomberg article Bird Flu Vaccine now 53% effective. US stockpile now able to help 4 million peope. Their Target stockpile will be able to help 20 million
Read the rest of this story

Previous Entries